YU64603A - Bubreći erodibilni matriks sistem sa kontrolisanim oslobađanjem aktivne supstance - Google Patents

Bubreći erodibilni matriks sistem sa kontrolisanim oslobađanjem aktivne supstance

Info

Publication number
YU64603A
YU64603A YU64603A YUP64603A YU64603A YU 64603 A YU64603 A YU 64603A YU 64603 A YU64603 A YU 64603A YU P64603 A YUP64603 A YU P64603A YU 64603 A YU64603 A YU 64603A
Authority
YU
Yugoslavia
Prior art keywords
active substance
controlled
agent
tablets
blowing
Prior art date
Application number
YU64603A
Other languages
English (en)
Inventor
Aleksandar Petrović
Original Assignee
Galenika A.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenika A.D. filed Critical Galenika A.D.
Priority to YU64603A priority Critical patent/RS52094B/en
Publication of YU64603A publication Critical patent/YU64603A/sh
Publication of RS52094B publication Critical patent/RS52094B/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Pronalazak se odnosi na farmaceutske proizvode, tablete i/ili filmom oblozene tablete, koje sadrze u visokoj dozi inkorporiranu jednu ili vise aktivnih supstanci razlicite rastvorljivosti i bubreci erodibilni polimer i/ili kanal formirajuce sredstvo-"chaneling agent" i/ili sredstvo za lubrikaciju i klizanje i/ili vezivno sredstavo i diluens i sloj film obloge sacinjen od filma formirajuceg polimera, plastifikatora, boja i/ili drugih farmaceutski prihvatljivih materija. Bubreci erodibilni matriks sistem u obliku tableta i/ili filmom oblozenih tableta razlicite genometrije i oblika, za oralnu primenu koje karakterise kontrolisano, kontinuirano oslobadanje aktivne supstance bez vremenskog odlaganja ili pilsacija, konstantnom brzinom u toku produzenog vremena (minimum 12 sati), kombinovanim mehanizmom kontrolisane difuzije aktivne supstance kroz gel sloj i kontrolisane erozije samog matriksa i postupak za njegovo dobijanje.
YU64603A 2003-08-12 2003-08-12 KIDNEY ERODIBLE MATRIX SYSTEM WITH CONTROLLED ACTIVE SUBSTANCE RELEASE RS52094B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU64603A RS52094B (en) 2003-08-12 2003-08-12 KIDNEY ERODIBLE MATRIX SYSTEM WITH CONTROLLED ACTIVE SUBSTANCE RELEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU64603A RS52094B (en) 2003-08-12 2003-08-12 KIDNEY ERODIBLE MATRIX SYSTEM WITH CONTROLLED ACTIVE SUBSTANCE RELEASE

Publications (2)

Publication Number Publication Date
YU64603A true YU64603A (sh) 2006-05-25
RS52094B RS52094B (en) 2012-06-30

Family

ID=37616573

Country Status (1)

Country Link
RS (1) RS52094B (sh)

Also Published As

Publication number Publication date
RS52094B (en) 2012-06-30

Similar Documents

Publication Publication Date Title
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
AU5680100A (en) Controlled release and taste masking oral pharmaceutical compositions
WO2002028376A3 (en) Chrono delivery formulations and method of use thereof
NZ333822A (en) Tramadol multiple unit formulations comprising individual pellets of trmadol coated with one or more membrane layers for controlling release
MXPA02007762A (es) Sistema de suministro de farmaco pulsativos temporalizados.
RS20080181A (en) Solid pharmaceutical compositions containing pregabalin, a matrix forming agent and a swelling agent
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
BR0312347A (pt) Composição farmacêutica oral, usos da espessura de revestimento de um material de revestimento dependente do ph de dissolução, de um material de revestimento, e de um material de polimetacrilato
DK0663820T3 (da) Farmaceutisk tablet, som er i stand til at frigive ét eller flere lægemidler med forskellige frigivelseshastigheder
AU6136199A (en) Dosage form comprising therapeutic formulation
AU2001254711A1 (en) Sustained release vitamin composition
AU1534699A (en) Osmotic dosage form comprising first and second coats
EP1275381A4 (en) SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
NO891680D0 (no) Osmotisk kontinuerlig avgivende oralt avgivelsessystem inneholdende et farmasoeytisk akseptabelt aktivt middel som har forbedrede kjernemembran-adhesjonsegenskaper.
DE69710757D1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
AP1954A (en) Controlled release compositions comprising nimesulide.
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
WO2006040779A3 (en) Controlled release gastric floating matrix formulation containing imatinib
WO2005027843A3 (en) Chronotherapeutic dosage forms
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative